Rebif New Formulation (RNF) Quality of Life (QOL) Study

NCT00472797 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

232

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis

Interventions

DRUG: Rebif New Formulation Non Titrated
DRUG: Rebif New Formulation Titrated

Sponsor

EMD Serono